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Abstract
Candida species are now one of the most common organisms isolated from hospitalized pa-
tients. The range of antifungal agents available is limited, and some of the most effective agents 
are also toxic. In the other hand plants have been used for thousands of years to flavor and 
conserve food, to treat health disorders and to prevent diseases including epidemics. The aim of 
this study was to investigate the antifungal effect of petroleumether, ethyl acetate and n-butanol 
fractions isolated from pomegranate pericarp and flower against Candida albicans (ATCC 3153). 
The maximum inhibition zone of Candida albicans was obtained by peel’s n-butanol fraction, 35 
mm. Petroleumether fractions had no any antifungal activities. 
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1. Introduction 
The Punica granatum L., is one of the oldest known edible fruits. It is native to Persia and from 
there it spreads into Asia, North Africa and Mediterranean Europe, including Turkey [1, 2]. Ac-
cording to Qur’an, Bible, Torah and Babylonian Talmud, pomegranate is a gif and heavenly fruit 
of God.
The extracts of traditional herbs have been shown to exert biological activity in vitro and in vivo. 
Punica granatum is employed in man medicine for the treatment of various diseases such as skin 
diseases, and wound healing, ulcers, fever, diarrhoea, and microbial infection. In the recently 
years, the Punica granatum has been the subject of much scientific research which have showed 
its antimicrobial, antioxidant and anti-cancer effects [3, 4].
The different types of phytochemical that have been showed identified from pomegranate 
pericarp (peel, rind) and pomegranate flower. Pomegranate pericarp’s constituents are Luteo-
lin, kaempferol, EA glycosides, EA, Pedunculagin, punicalin, phenolic punicalagins, Gallic acid 
and other fatty acids, catechin, EGCG, quercetin, rutin and other flavonols, flavones, flavonones, 
anthocyanidins. Pomegranate flower’s constituents are Polyphones, punicalagins punicalin, EA, 
Gallic acid, ursolic acid, triterpenoids, including maslinic and Asiatic acid [1, 5- 7].
Candida species are harmless saprophyte yeasts, a normal component of the human biota in the 
gastrointestinal tract and oral and vaginal mucosae. These yeasts can cause superficial infections 
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such as thrush and vaginitis; however, if the immune defences of the host become compromised, 
they can cause severe systemic infections. Risk factors for patients include infection by the hu-
man immunodeficiency virus (HIV), anticancer therapy, organ transplantation, abdominal sur-
gery, catheters, diabetes and the use of broad-spectrum antibiotics [4, 11].
The aim of this study was to investigate the antifungal effect of some fractions isolated from 
pomegranate pericarp and flower against Candida albicans.
2. Materials and Methods
Samples of P. Granatum flowers and peels were collected and identification in June and Septem-
ber 2011 respectively from the Agricultural Research Centre in Isfahan, Iran.
The flowers and peels were air-dried in a low light at room temperature for 1 weak. The material 
was thereafter ground in an electric grinder to produce a powder separately.
Peels and flowers powder extracted with 100% petroleumether (F1) at room temperature for 24 
hours respectively, the extracts were filtered. Then 20 gram of remains powders were extracted 
with 75% Ethanol by Soxhlet extraction for 8 hours.
The residues were dried over night and then evaporated by using a rotary evaporator. The dried 
extracts were suspended in distilled water (F2) and partition with ethyl acetate (F3) followed by 
n-butanol (F4). All fractions were frigid at -20°C until each experiment.
The yeast strain C. albicans (ATCC 3153) were used in this study. It obtained from Institute of 
Scientific and Industrial Researches, Tehran, Iran. At the first, it has been maintained at 4°C on 
Sabouraud dextrose agar (SDA) plates and sub cultured at 25°C in Sabouraud dextrose broth 
(SDB) before each experiment to ensure viability and purity. 
Petri dishes contained 20 ml of SDA have been used for well-diffusion assay. Wells have been 
prepared in the SDA plates. In agar well diffusion, 10, 50, 100 and 200 μl of each fractions have 
been inoculated to each well separately. Then 100 ml of 106 CFU/ml yeast suspension was spread 
uniformly onto the agar plate using cotton swabs. Diameters (in mm) of growth inhibition zones 
were measured after incubation at 25°C for 24- 48 hours.
3. Results and Discussion 
Candida species are now the fourth most common organism recovered from the blood of hospi-
talized patients. Notwithstanding the increasing need for effective therapy, the range of antifun-
gal agents available is limited, and some of the most effective agents are also toxic. In addition, 
although azoles have been used successfully for the treatment of Candida infections, numerous 
reports of treatment failures are now appearing in the literature [4]. In view of the lack of new 
classes of drugs or different molecular targets, drug combinations might be considered a viable 
strategy for therapy, considering the multiplicity of fungal targets against which current agents 
are effective.
 The antimicrobial and antifungal effects of alcoholic extracts of different parts of pomegranate 
tree were previously studied [1, 8-11]. Nevertheless, few studies have showed the antifungal ef-
fect of different pomegranate fractions. This study showed the antifungal activity of 4 pomegran-
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ate fractions. Antifungal effects of peel and flower fractions by well-diffusion assay method have 
been shown in Figure 1 and Figure 2 respectively. 
The maximum inhibition zones of peel fractions against C. albicans ATCC 3153 were obtained in 
200 μl concentrations by n- butanol fraction, water fraction and ethyl acetate fraction respectively.
 C. albicans ATCC 3153 only was sensitive to flower n- butanol fraction. In addition C. Albicans 
ATCC 3153 was resistant to peel and flower Petroleumether fractions.
The fractions had no any antifungal activity in 10 μl, and there was direct relationship between 
concentration and inhibition zone.
Also, n- butanol, ethyl acetate, water and petroleumether had no any antifungal activities. In the 
other words, the extracted compounds of peel and flower were effective [4].
Figure 1. The inhibitory zons (mm) of peel’s fractions in 4 concentrations against C. albicans (ATCC 3153).  
F1: Petroleumether Fraction, F2: Water Fraction, F3: Ethyl acetate Fraction, F4: n-butanol Frcation.
Figure 2. The inhibitory zones (mm) of flower’s fractions in 4 concentrations against C. albicans (ATCC 3153). 
F1: Petroleumether Fraction, F2: Water Fraction, F3: Ethyl acetate Fraction, F4: n-butanol Frcation. 
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